Media & Entertainment

CEO Jayme Mendal’s disciplined 10b5‑1 buy‑sell on EverQuote signals strategic rebalancing, not distress—insight for long‑term investors.

Harry Sloan’s latest LIONSGATE stock purchase signals confidence in the company’s new HDT Bio partnership and its RNA‑manufacturing future.

Insider buying shows bullish confidence in Lionsgate’s new biotech push, as Rachesky’s recent purchase aligns with an RNA platform partnership and rising market buzz.

Quantum X Labs insider buys signal strong upside: Co‑CEO Baranes Yakov adds 5,000 shares amid rapid price gains and new advisory board member Yossi Cohen, boosting confidence in its quantum‑computing and cybersecurity roadmap.

Boston Omaha’s insider moves reveal a strategic balance: a board member’s 5,252‑share grant and large sale, amid fresh board buys, signals confidence and liquidity support for shareholders.

Boston Omaha’s surge of insider buying signals confidence and potential upside—learn how new purchases could curb dilution and lift the stock before its September sale.

Pin’s insider, Benjamin Silbermann, buys and sells 46,875 shares in a disciplined Rule 10b‑5‑1 round‑trip, revealing cautious confidence amid a low valuation.

Insider selling spree at MediaAlpha: 28,777 shares sold under a 10b‑5‑1 plan—does it signal confidence or caution? Find out what it means for traders and long‑term investors.

Trade Desk CEO’s new 7‑million share‑option purchase signals confidence in the company’s growth and a strong future for the stock.

Meta COO’s recent share sales hint at investor sentiment around the new Muse AI rollout—what it means for stock moves and regulatory risk.